CompletedPhase 3

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

Syria18,404 participantsStarted 2021-02-01

Plain-language summary

The aim of this study is to determine the efficacy of Mosquito Shield (spatial repellent) in reducing cutaneous leishmaniasis case incidence among internally displaced persons and sandfly density in temporary shelters and camp settings in Ar-Raqqa governorate, North-East Syria.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Known history of cutaneous leishmaniasis in camp Sleeping under same shelter type (all UNHCR tents / plastic sheets) Camp easily accessible by road Camps a minimum of 5km apart Adequate security levels Exclusion Criteria: Camps closer than 5km from a camp included in the study Camps with no previously recorded cases of cutaneous leishmaniasis Displaced communities living outside of defined camp settings

What they're measuring

Epidemiological outcome: cutaneous leishmaniasis incidence

Timeframe: 11 or 9 months

Entomological outcome: phlebotomine sandfly density

Timeframe: 9 months

Trial details

NCT IDNCT06917040

SponsorThe Mentor Initiative

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More Leishmaniasis, Cutaneous trials